Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study

<b>Background:</b> Subarachnoid hemorrhage (SAH) is associated with high mortality and a high level of disability. Progress in surgical and endovascular techniques has lowered the mortality rate in patients with SAH. However, many patients are left with neurological impairment. <b>...

Full description

Saved in:
Bibliographic Details
Main Authors: Klaudyna Kojder, Konrad Jarosz, Agata Andrzejewska, Joanna Solek-Pastuszka, Karolina Skonieczna-Żydecka, Mariusz Kaczmarczyk, Anna Jurczak
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/11/2492
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846154243214409728
author Klaudyna Kojder
Konrad Jarosz
Agata Andrzejewska
Joanna Solek-Pastuszka
Karolina Skonieczna-Żydecka
Mariusz Kaczmarczyk
Anna Jurczak
author_facet Klaudyna Kojder
Konrad Jarosz
Agata Andrzejewska
Joanna Solek-Pastuszka
Karolina Skonieczna-Żydecka
Mariusz Kaczmarczyk
Anna Jurczak
author_sort Klaudyna Kojder
collection DOAJ
description <b>Background:</b> Subarachnoid hemorrhage (SAH) is associated with high mortality and a high level of disability. Progress in surgical and endovascular techniques has lowered the mortality rate in patients with SAH. However, many patients are left with neurological impairment. <b>Objectives:</b> In our study we wanted to examine the impact of Cerebrolysin on treatment results in patients with SAH diagnosis. <b>Methods:</b> The data of 47 patients, divided into Cerebrolysin (26) and non-Cerebrolysin (21) group were included. We examined the correlation between Cerebrolysin administration and additional Amantadine treatment or neuromonitoring, craniectomy, and endovascular treatment and its impact on the Glasgow Outcome Scale (GOS) score, length of stay (LOS), and mortality. <b>Results:</b> Our study shows that Cerebrolysin improves the mortality rate in combination with neuromonitoring in a group of patients with severe SAH. It does not affect the raw values of GOS or LOS in patients with SAH. <b>Conclusions:</b> Further studies with larger patient groups are needed to investigate the role of Cerebrolysin as an additional treatment in SAH.
format Article
id doaj-art-57eef80fb6da45da8a0d89498e9f2ee9
institution Kabale University
issn 2227-9059
language English
publishDate 2024-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-57eef80fb6da45da8a0d89498e9f2ee92024-11-26T17:52:59ZengMDPI AGBiomedicines2227-90592024-10-011211249210.3390/biomedicines12112492Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort StudyKlaudyna Kojder0Konrad Jarosz1Agata Andrzejewska2Joanna Solek-Pastuszka3Karolina Skonieczna-Żydecka4Mariusz Kaczmarczyk5Anna Jurczak6Anesthesiology and Intensive Care Department, Pomeranian Medical University, Rybacka 1 str., 70-204 Szczecin, PolandAnesthesiology and Intensive Care Department, Pomeranian Medical University, Rybacka 1 str., 70-204 Szczecin, PolandAnesthesiology and Intensive Care Department, Pomeranian Medical University, Rybacka 1 str., 70-204 Szczecin, PolandAnesthesiology and Intensive Care Department, Pomeranian Medical University, Rybacka 1 str., 70-204 Szczecin, PolandDepartment of Biochemical Science, Pomeranian Medical University in Szczecin, Broniewskiego 24, 71-460 Szczecin, PolandDepartment of Biochemical Science, Pomeranian Medical University in Szczecin, Broniewskiego 24, 71-460 Szczecin, PolandDepartment of Specialist Nursery, Pomeranian Medical University, Zolnierska Str. 48, 71-210 Szczecin, Poland<b>Background:</b> Subarachnoid hemorrhage (SAH) is associated with high mortality and a high level of disability. Progress in surgical and endovascular techniques has lowered the mortality rate in patients with SAH. However, many patients are left with neurological impairment. <b>Objectives:</b> In our study we wanted to examine the impact of Cerebrolysin on treatment results in patients with SAH diagnosis. <b>Methods:</b> The data of 47 patients, divided into Cerebrolysin (26) and non-Cerebrolysin (21) group were included. We examined the correlation between Cerebrolysin administration and additional Amantadine treatment or neuromonitoring, craniectomy, and endovascular treatment and its impact on the Glasgow Outcome Scale (GOS) score, length of stay (LOS), and mortality. <b>Results:</b> Our study shows that Cerebrolysin improves the mortality rate in combination with neuromonitoring in a group of patients with severe SAH. It does not affect the raw values of GOS or LOS in patients with SAH. <b>Conclusions:</b> Further studies with larger patient groups are needed to investigate the role of Cerebrolysin as an additional treatment in SAH.https://www.mdpi.com/2227-9059/12/11/2492SAHCerebrolysinneuromonitoring
spellingShingle Klaudyna Kojder
Konrad Jarosz
Agata Andrzejewska
Joanna Solek-Pastuszka
Karolina Skonieczna-Żydecka
Mariusz Kaczmarczyk
Anna Jurczak
Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study
Biomedicines
SAH
Cerebrolysin
neuromonitoring
title Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study
title_full Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study
title_fullStr Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study
title_full_unstemmed Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study
title_short Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study
title_sort cerebrolysin in patients diagnosed with subarachnoid hemorrhage the results of an observational cohort study
topic SAH
Cerebrolysin
neuromonitoring
url https://www.mdpi.com/2227-9059/12/11/2492
work_keys_str_mv AT klaudynakojder cerebrolysininpatientsdiagnosedwithsubarachnoidhemorrhagetheresultsofanobservationalcohortstudy
AT konradjarosz cerebrolysininpatientsdiagnosedwithsubarachnoidhemorrhagetheresultsofanobservationalcohortstudy
AT agataandrzejewska cerebrolysininpatientsdiagnosedwithsubarachnoidhemorrhagetheresultsofanobservationalcohortstudy
AT joannasolekpastuszka cerebrolysininpatientsdiagnosedwithsubarachnoidhemorrhagetheresultsofanobservationalcohortstudy
AT karolinaskoniecznazydecka cerebrolysininpatientsdiagnosedwithsubarachnoidhemorrhagetheresultsofanobservationalcohortstudy
AT mariuszkaczmarczyk cerebrolysininpatientsdiagnosedwithsubarachnoidhemorrhagetheresultsofanobservationalcohortstudy
AT annajurczak cerebrolysininpatientsdiagnosedwithsubarachnoidhemorrhagetheresultsofanobservationalcohortstudy